Výsledky vyhledávání - "Ruth Soto-Malave"

Safety and Efficacy of Ombitasvir, Paritaprevir With Ritonavir ± Dasabuvir With or Without Ribavirin in Patients With Human Immunodeficiency Virus-1 and Hepatitis C Virus Genotype 1 or Genotype 4 Coinfection: TURQUOISE-I Part 2

Publikováno v: Open Forum Infectious Diseases
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname

Background Ombitasvir, paritaprevir with ritonavir, and dasabuvir (OBV/PTV/r ± DSV) ±ribavirin (RBV) are approved to treat hepatitis C virus (HCV) genotype 1 and 4 infection. Here, we investigate the safety and efficacy of OBV/PTV/r + DSV ±RBV for

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c6961fa3ddec3fa06f99a2c4235b26e1
https://doi.org/10.1093/ofid/ofx154

Zobrazit plný text záznamu

1965. Safety and Efficacy of Glecaprevir/Pibrentasvir in Patients With Chronic Hepatitis C Virus Genotypes 1–6 and Human Immunodeficiency Virus-1 Co-Infection: An Integrated Analysis of Two Phase 3 Clinical Trials

Autor: Roger Trinh, Stanley Wang, Ruth Soto-Malave, Sanjay Bhagani, Zhenzhen Zhang, Karine Lacombe, Federico J. Mensa, Jürgen K. Rockstroh, Chloe Orkin

Publikováno v: Open Forum Infectious Diseases

Background People co-infected with hepatitis C virus (HCV) and human immunodeficiency virus (HIV)-1 may be treated for HCV without special considerations apart from drug interactions with antiretroviral therapies (ART). The once-daily, all-oral, riba

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::60b164163a7da1a651ee8d002e32b30d
https://doi.org/10.1093/ofid/ofy210.1621

Zobrazit plný text záznamu

Lopinavir/Ritonavir Combined with Raltegravir or Tenofovir/Emtricitabine in Antiretroviral-Naive Subjects: 96-Week Results of the PROGRESS Study

Autor: Roger Trinh, Thomas Podsadecki, Joseph Gathe, Ruth Soto-Malave, Michael Norton, Jacques Reynes, Min Tian, Linda M Fredrick, Roula B Qaqish, Angela Nilius, Federico Pulido

Publikováno v: AIDS Research and Human Retroviruses. 29:256-265

Alternative combinations of antiretrovirals (ARVs) are desired to increase treatment options for HIV-infected patients. PROGRESS was a randomized, open-label, 96-week pilot study comparing a regimen of lopinavir/ritonavir (LPV/r) 400/100 mg twice dai

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4bf9a60498b7c850279bc106cab758e6
https://doi.org/10.1089/aid.2011.0275

Zobrazit plný text záznamu

Multiple Simultaneous Gastrointestinal Parasitic Infections in a Patient with Human Immunodeficiency Virus

Autor: Esteban A, Del Pilar-Morales, Zaydalee, Cardona-Rodríguez, Jorge, Bertrán-Pasarell, Ruth, Soto-Malave, Rafeal, De León-Borras

Publikováno v: Puerto Rico health sciences journal. 35(2)

Patients with the human immunodeficiency virus (HIV) infection are at high risk for gastrointestinal infections causing diarrhea, particularly when those infections are parasitic in nature. This propensity is more pronounced in AIDS, where opportunis

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::1a88a00a4e02af6706fd7c7a59674d4a
https://pubmed.ncbi.nlm.nih.gov/27232872

Zobrazit plný text záznamu

Efficacy and safety of Glecaprevir/Pibrentasvir in patients co-infected with hepatitis C virus and human immunodeficiency virus-1: the EXPEDITION-2 Study

Autor: Roger Trinh, Juergen K. Rockstroh, Jihad Slim, Sanjay Bhagani, Kenneth E. Sherman, Chloe Orkin, Ruth Soto-Malave, Karine Lacombe, Joe Sasadeusz, T. Shimonova, Mark S. Sulkowski, Teresa I. Ng, Peter Ruane, Zhenzhen Zhang, Rolando M Viani, Robert Flisiak, David L. Wyles, Annie Luetkemeyer

Publikováno v: Journal of Hepatology. 66:S102-S103

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c91871a6f65379669be65dc8010c5926
https://doi.org/10.1016/s0168-8278(17)30467-1

Zobrazit plný text záznamu

Examination of noninferiority, safety, and tolerability of lopinavir/ritonavir and raltegravir compared with lopinavir/ritonavir and tenofovir/ emtricitabine in antiretroviral-naïve subjects: the progress study, 48-week results

Autor: Joseph Gathe, Adebayo Lawal, Ruth Soto-Malave, Angela Nilius, Min Tian, Federico Pulido, Jacques Reynes, Thomas Podsadecki, Linda M Fredrick

Publikováno v: HIV clinical trials. 12(5)

Current antiretroviral regimens recommended for treatment-naïve patients include 2 nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs). The purpose of this study is to evaluate whether a new NRTI-sparing regimen may provide an alternative

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d2a0ccbc07e9f36726345a3de8d4abb3
https://pubmed.ncbi.nlm.nih.gov/22180523

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání